Evidence map›Paper›PMID 35919032›Full record

SynthesisGenetics research2022

Association of the

Brehima Diakite, Yaya Kassogue, Mamoudou Maiga, Guimogo Dolo, Oumar Kassogue, Jonah Musa, Imran Morhason-Bello, Ban Traore, Cheick Bougadari Traore, Bakarou Kamate and 6 more

Open access · goldAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Genetics research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Association of theGenetics research · 2022
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 4 countries.

Brehima DiakiteCentre de Recherche et de Formation sur les Pathologies Moleculaires (CREFPAM), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.ORCID 0000-0001-8296-5292
Yaya KassogueCentre de Recherche et de Formation sur les Pathologies Moleculaires (CREFPAM), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Mamoudou MaigaCentre de Recherche et de Formation sur les Pathologies Moleculaires (CREFPAM), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Guimogo DoloCentre de Recherche et de Formation sur les Pathologies Moleculaires (CREFPAM), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Oumar KassogueCentre de Recherche et de Formation sur les Pathologies Moleculaires (CREFPAM), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Jonah MusaPreventive Medicine Department, Cancer Epidemiology and Prevention, Northwestern University, Chicago, Illinois 60611, USA.
Imran Morhason-BelloDepartment of Obstetrics and Gynecology, Faculty of Clinical Sciences and Institute for Advanced Medical Research and Training (IAMRAT), College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
Ban TraoreFaculty of Sciences and Techniques, USTTB, Bamako, Mali.
Cheick Bougadari TraoreCentre de Recherche et de Formation sur les Pathologies Moleculaires (CREFPAM), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Bakarou KamateCentre de Recherche et de Formation sur les Pathologies Moleculaires (CREFPAM), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Aissata CoulibalyCentre de Recherche et de Formation sur les Pathologies Moleculaires (CREFPAM), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali.
Sekou BahFaculty of Pharmacy, USTTB, Bamako, Mali.
Sellama NadifiHassan II University Aïn Chock, Casablanca, Morocco.
Robert MurphyInstitute for Global Health, Northwestern University, Chicago, Illinois 60611, USA.
Jane L HollDepartment of Neurology, University of Chicago, Chicago, Illinois 60611, USA.
Lifang HouPreventive Medicine Department, Cancer Epidemiology and Prevention, Northwestern University, Chicago, Illinois 60611, USA.
Université des Sciences, des Techniques et des Technologies de Bamako · MLNorthwestern University · USUniversity of Chicago · USUniversity of Hassan II Casablanca · MAUniversity of Ibadan · NG

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Partnership for Global Health Research Training Program (Renewal)-Supplement for OBSSR, NCI, NCI-AIDS and NIDCDD43TW010543 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, DAVIDSON HOWES HAMER · 2017 to 2026
$12.1M
West Africa Self-Sampling HPV Based Cervical Cancer Control Program (WA-SS-HCCP) for WLWHA: Barriers, challenges, and needsU01CA275129 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI JANE Louise HOLL, Lifang Hou · 2022 to 2026
$3.2M
Infection-Associated Cancer Research Training Program in MaliD43CA260658 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HOU, LIFANG, MAIGA, MAMOUDOU · 2021 to 2025
$1.3M
FIC NIH HHS D43 TW010543NCATS NIH HHS UL1 TR001422NCI NIH HHS D43 CA260658NCI NIH HHS U01 CA275129
6 · The paper itself

Abstract

A literature review showed some discrepancies regarding the association of

Indexed as

Interleukin-10Uterine Cervical NeoplasmsAsian PeopleFemaleGenetic Predisposition to DiseaseHumansPolymorphism, Single NucleotideRisk FactorsInterleukin-10

Identifiers

PMID35919032
PMCPMC9296312
OpenAlexW4285093986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.